Macerich (MAC) Aandelenoverzicht
The Macerich Company is een volledig geïntegreerde, zelfbeheerde, zelfbestuurde vastgoedbevak (REIT). Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 0/6 |
| Dividenden | 3/6 |
MAC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
The Macerich Company Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$24.36 |
| 52 Week Hoogtepunt | US$26.68 |
| 52 Week Laag | US$16.03 |
| Bèta | 2.07 |
| 1 maand verandering | -5.69% |
| 3 maanden verandering | 8.31% |
| 1 Jaar Verandering | 35.03% |
| 3 jaar verandering | 115.00% |
| 5 jaar verandering | 44.74% |
| Verandering sinds IPO | 24.92% |
Recent nieuws en updates
Narratiefupdate • Aug 18
MAC: Path Forward Plan And Financing Moves Will Guide Balanced Repricing Potential
The analyst price target for Macerich has moved modestly higher, with the updated fair value estimate rising from $25.75 to $26.63 as analysts cite ongoing leasing progress, Path Forward Plan execution, and adjusted retail REIT models following recent earnings updates. Analyst Commentary Recent research updates on Macerich give you a mixed but generally constructive picture, with many firms lifting price targets while still watching execution risk around the Path Forward Plan, acquisitions, and valuation.
Narratiefupdate • Aug 04
MAC: Equity Raises For Acquisitions May Cap Upside Despite Path Forward Progress
The updated Macerich price target of $21.23 reflects a modest increase from $19.85, aligning with analysts' higher $24 to $30 targets that are supported by progress on the Path Forward Plan, leasing momentum, adjusted FFO outlooks, and acquisition funding capacity. Analyst Commentary Recent research on Macerich shows a mix of optimism on the Path Forward Plan and leasing progress, alongside a clear pocket of caution around valuation, execution risk, and the durability of growth.Recent updates
Narratiefupdate • Aug 18
MAC: Path Forward Plan And Financing Moves Will Guide Balanced Repricing Potential
The analyst price target for Macerich has moved modestly higher, with the updated fair value estimate rising from $25.75 to $26.63 as analysts cite ongoing leasing progress, Path Forward Plan execution, and adjusted retail REIT models following recent earnings updates. Analyst Commentary Recent research updates on Macerich give you a mixed but generally constructive picture, with many firms lifting price targets while still watching execution risk around the Path Forward Plan, acquisitions, and valuation.Narratiefupdate • Aug 04
MAC: Equity Raises For Acquisitions May Cap Upside Despite Path Forward Progress
The updated Macerich price target of $21.23 reflects a modest increase from $19.85, aligning with analysts' higher $24 to $30 targets that are supported by progress on the Path Forward Plan, leasing momentum, adjusted FFO outlooks, and acquisition funding capacity. Analyst Commentary Recent research on Macerich shows a mix of optimism on the Path Forward Plan and leasing progress, alongside a clear pocket of caution around valuation, execution risk, and the durability of growth.Narratiefupdate • Jul 21
MAC: Path Forward Plan And Equity Raises Will Shape Balanced Repricing Potential
The analyst price target for Macerich has been raised from $24.31 to $25.75. This change reflects analysts' updated views on the company's "Path Forward Plan," leasing progress, acquisition funding from recent equity issuance, and revised FFO and valuation assumptions across several firms.Narratiefupdate • Jul 07
MAC: Equity Raises And Path Forward Execution Risks May Limit Upside
The analyst price target for Macerich has been lifted from $19.00 to about $19.85 as analysts factor in higher price objectives across the Street, citing progress on the "Path Forward Plan," improved leasing trends, updated FFO assumptions, and the potential impact of recent acquisition and funding activity. Analyst Commentary Recent Street research on Macerich shows a mix of optimism about the Path Forward Plan and leasing progress, alongside a pocket of caution around valuation, funding choices, and execution risk on longer term earnings targets.Seeking Alpha • Jun 25
Macerich: Growth Story Hobbled By Debt
Summary Macerich is undergoing a major transformation, focusing on high-performing Class A malls and targeting Gen Z consumers for future growth. Despite impressive portfolio streamlining and leasing momentum, MAC remains constrained by high debt levels, elevated interest rates, and a below-average dividend yield. FFO per share is forecast to grow 11.3% in 2026 and 11.9% in 2027, with acquisitions and dispositions expected to balance out in 2026. Read the full article on Seeking AlphaNarratiefupdate • Jun 23
MAC: Path Forward Plan And Equity Raises May Support Measured Repricing Ahead
The analyst price target for Macerich has been raised from $23.13 to $24.31, with analysts citing progress on the "Path Forward" plan, improved earnings visibility, and updated targets across multiple firms as key drivers behind the change. Analyst Commentary Recent research on Macerich reflects a mix of optimism around the "Path Forward" plan and more cautious views on valuation and execution risk.Analyse-artikel • Jun 17
Macerich (MAC) Stock Could Be 25.5% Below Fair Value Despite Mixed Valuation Views
Macerich (MAC) stock has drawn investor attention after its recent performance, with the share price closing at $23.75 and total return figures highlighting a mix of shorter and longer term outcomes. See our latest analysis for Macerich. Recent trading has been choppy for Macerich, with the share price falling 5.34% over the last day even after a 30 day share price return of 9.95% and a year to date share price return of 28.24%. The 1 year total shareholder return of 55.45% and 3 year total...Narratiefupdate • Jun 07
MAC: Path Forward Plan And Deleveraging May Support Measured Repricing Ahead
Narrative Update The analyst price target for Macerich moves from $21.63 to $23.13 as analysts respond to the company's "Path Forward Plan," completed balance sheet deleveraging and portfolio simplification, modest guidance adjustments, and updated models following recent equity and earnings developments. Analyst Commentary Recent research on Macerich shows a mix of optimism and caution, with several firms updating models and price targets following the "Path Forward Plan," balance sheet changes, and an equity raise.Narratiefupdate • May 24
MAC: Equity Raise And Execution Risks Will Cap Future Upside Potential
Analysts have lifted the price target on Macerich to $19.00 from $15.58, citing refreshed models that reflect updated guidance, adjusted expectations for revenue decline and margins, and a range of recent price target increases across the Street. Analyst Commentary Recent Street research around Macerich points to a mix of optimism on execution and balance sheet progress, alongside ongoing debate about how fully the stock already reflects these improvements.Narratiefupdate • May 07
MAC: Path Forward Execution And Deleveraging May Support Balanced Repricing Ahead
Analysts have raised their average price target for Macerich by a few dollars to reflect recent target increases across several research firms, citing progress on the company's multi year "Path Forward Plan," asset sales, and balance sheet improvement as key supports for the updated view. Analyst Commentary Recent research updates present a mixed picture on Macerich, with several price target increases and a couple of rating changes that highlight both improving execution and ongoing debates about valuation and risk.Narratiefupdate • Apr 20
MAC: Path Forward Execution And Deleveraging Support Balanced Outlook As Models Update
The analyst price target for Macerich edges up from $21.38 to $21.63, as analysts factor in a modestly lower discount rate, steady revenue and margin assumptions, and recent Street research that highlights execution on the "Path Forward Plan," asset sales, deleveraging, and updated valuation models across several firms. Analyst Commentary Recent Street research on Macerich reflects a mix of optimism about the company’s execution and balance sheet progress, alongside ongoing caution on valuation and long term earnings power.Narratiefupdate • Apr 05
MAC: Path Forward Execution And Deleveraging Shape Balanced Outlook For Future Returns
Analysts nudged Macerich's fair value estimate to $21.38 from $21.19, citing updated models that reflect improved profit margin assumptions, a lower discount rate, and recent price target increases across the Street. Analyst Commentary Recent Street research on Macerich clusters around higher price targets and rating changes, with opinions split between optimism on execution and caution on valuation and sector fundamentals.Narratiefupdate • Mar 21
MAC: Path Forward Deleveraging And Asset Sales Will Drive Future Returns
The analyst price target for Macerich increases from $21.13 to $21.19 as analysts factor in updated models, recent price target revisions across the Street, and progress against the company's multi-year "Path Forward Plan." Analyst Commentary Recent research updates on Macerich reflect a mix of optimism around execution on the "Path Forward Plan" and caution on valuation and sector fundamentals. Price targets now span from the high teens to the mid twenties, with ratings ranging from Sell to Overweight.Narratiefupdate • Mar 07
MAC: Path Forward Execution And Deleveraging Will Shape Future Returns
The analyst price target for Macerich has moved higher to $21.13 from $20.13 as analysts point to updated expectations for the company’s Path Forward Plan, improving margin assumptions and revised P/E and discount rate inputs in recent research. Analyst Commentary Recent Street research on Macerich shows a mix of optimism around execution on the Path Forward Plan and caution around valuation and sector headwinds.Narratiefupdate • Feb 20
MAC: Peak Fundamentals And Occupancy Levels Will Limit Future Upside Potential
Analysts have lifted their price targets on Macerich, including one increase to $21. This change reflects updated views on discount rates, revenue trends, profit margins, and future P/E assumptions.Narratiefupdate • Feb 06
MAC: Sector Peak Concerns And Occupancy Expectations Will Shape Future Returns
Analysts have nudged their fair value estimate for Macerich up from about $19.86 to $20.13, citing a series of recent price target increases and updated sector views that reflect current expectations for occupancy and earnings quality. Analyst Commentary Bullish Takeaways Bullish analysts highlight the series of price target resets, from US$18 to US$19 and then above US$20, as support for a modestly higher fair value range for the shares.Narratiefupdate • Jan 22
MAC: Peak Occupancy Concerns Will Constrain Future Upside Potential
Narrative update on Macerich Analysts have nudged their fair value estimate for Macerich to about US$15.58 from US$15.00, reflecting recent price target increases across the Street as they refresh assumptions on growth, margins and long term P/E expectations. Analyst Commentary Recent Street research on Macerich has centered on refreshed price targets and sector views as firms revisit their models for U.S. real estate and REITs. While individual targets differ, the common thread is a reassessment of mall and shopping center fundamentals alongside updated assumptions for occupancy and earnings power.Narratiefupdate • Jan 08
MAC: Lower Discount Rate And P/E Assumptions Will Shape Future Returns
Narrative update on Macerich Analysts have lifted their price target on Macerich to about $19.86 from $19.53, reflecting updated views on discount rates, revenue trends, margins and long term P/E assumptions, in line with recent Street research that raised one target to $19. Analyst Commentary Recent commentary focuses on how updated discount rates, revenue trends, margin assumptions and long term P/E expectations feed into the fair value range for Macerich.Narratiefupdate • Sep 20
Experiential Retail Trends Will Revitalize Urban Leasing
Analysts modestly increased Macerich’s price target to $19.53, citing improved Q2 performance and a sector-wide REIT valuation reassessment, though concerns about the company’s risk profile persist. Analyst Commentary Bullish analysts increased price targets following updated financial models that reflect improved Q2 performance.
Nieuw narratief • Feb 10
Rising Interest Rates And Debt Reduction Plans May Erode Future Earnings
Reducing debt and strategic asset sales may cause revenue instability and transitional earnings impacts during restructuring efforts.Seeking Alpha • Jan 07
Is Macerich Now A Buy?
Summary Macerich has rallied heavily over the last year as market enthusiasm builds over its Path Forward Plan. The REIT is currently trading for 13.5x times its annualized third-quarter FFO and offers a modest 3.31% dividend yield. The November equity offering should be accretive, but revenue is set to dip in future quarters on asset sales and givebacks. Read the full article on Seeking AlphaSeeking Alpha • Oct 16
Macerich: Old Retail Is Fading
Summary Macerich is a REIT focused on malls and shopping centers, currently yielding 3.8%, with no clear growth story. Management aims to reduce debt by $2B through asset sales, but this likely means revenue and cash flows will decline in the near term. E-commerce growth and the shift from brick-and-mortar retail present significant challenges, making MAC's turnaround and profitable growth uncertain. Read the full article on Seeking AlphaRendement voor aandeelhouders
| MAC | US Retail REITs | US Markt | |
|---|---|---|---|
| 7D | -1.2% | -0.8% | -1.2% |
| 1Y | 35.0% | 14.0% | 18.3% |
Rendement versus industrie: MAC overtrof de US Retail REITs industrie, die het afgelopen jaar een rendement 14 % opleverde.
Rendement versus markt: MAC overtrof de US markt, die het afgelopen jaar een rendement opleverde van 18.3 %.
Prijsvolatiliteit
| MAC volatility | |
|---|---|
| MAC Average Weekly Movement | 4.5% |
| Retail REITs Industry Average Movement | 2.9% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: MAC heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van MAC is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1964 | 597 | Jackson Hsieh | www.macerich.com |
The Macerich Company is een volledig geïntegreerde, zelfstandig beheerde en zelfstandig geleide vastgoedbeleggingsmaatschappij (REIT). Als toonaangevende eigenaar, exploitant en ontwikkelaar van hoogwaardig winkelvastgoed in dichtbevolkte en aantrekkelijke Amerikaanse markten, is de portefeuille van Macerich geconcentreerd in Californië, de Pacific Northwest, Phoenix/Scottsdale en de corridor tussen de metropoolregio’s New York en Washington, D.C. Macerich ontwikkelt en beheert vastgoedobjecten die als hoekstenen van de gemeenschap fungeren en bezit momenteel ongeveer 40 miljoen vierkante voet aan vastgoed, voornamelijk bestaande uit belangen in 38 winkelcentra.
The Macerich Company Samenvatting
| MAC fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$7.20b |
| Inkomsten(TTM) | -US$170.35m |
| Inkomsten(TTM) | US$1.03b |
6.7x
P/S-verhouding-40.6x
Koers/WinstverhoudingIs MAC overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| MAC resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$1.03b |
| Kosten van inkomsten | US$463.22m |
| Brutowinst | US$564.20m |
| Overige uitgaven | US$734.55m |
| Inkomsten | -US$170.35m |
Laatst gerapporteerde inkomsten
Jun 30, 2026
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.60 |
| Brutomarge | 54.91% |
| Nettowinstmarge | -16.58% |
| Schuld/Eigen Vermogen Verhouding | 166.7% |
Hoe presteerde MAC op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
2.8%
Huidig dividendrendement45%
UitbetalingsratioBetaalt MAC een betrouwbaar dividend?
Zie MAC dividendgeschiedenis en benchmarks| Macerich dividenddata | |
|---|---|
| Ex Dividend Datum | Sep 14 2026 |
| Betaaldatum dividend | Sep 28 2026 |
| Dagen tot Ex-dividend | 20 days |
| Dagen tot dividendbetaaldatum | 34 days |
Betaalt MAC een betrouwbaar dividend?
Zie MAC dividendgeschiedenis en benchmarksBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/08/24 23:13 |
| Aandelenkoers aan het einde van de dag | 2026/08/24 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
The Macerich Company wordt gevolgd door 35 analisten. 7 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| null null | Argus Research Company |
| Ross Smotrich | Barclays |
| Paul Adornato | BMO Capital Markets Equity Research |